JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritisLouise Gillard, Stéphane Mitrovic, J. Pouchot et al.|Lara D. Veeken|2022Cited by 63
AB0772 JAK INHIBITORS IN REFRACTORY ADULT AND CHILDHOOD ONSET STILL'S DISEASELouise Gillard, Bruno Fautrel, Stéphane Mitrovic et al.|Annals of the Rheumatic Diseases|2021Cited by 7
Les inhibiteurs de JAK dans la maladie de Still réfractaireL. Gillard, Héloïse Reumaux, Isabelle Koné‐Paut et al.|Revue du Rhumatisme|2021Cited by 0
SA17 ON-DEMAND TREATMENTS FOR HEREDITARY ANGIOEDEMA AND HEALTHCARE RESOURCE UTILIZATION IN PEDIATRIC (2-11 YEARS) PATIENTS: A US CLAIMS DATABASE ANALYSISRaffi Tachdjian, Alice Wang, Bob Geng et al.|Value in Health|2026Cited by 0